Glass House Brands (GLAS) Deferred Taxes (2020 - 2024)
Glass House Brands' (GLAS) quarterly Deferred Taxes came in at $834000.0 in Q1 2024, up 990.35% year-on-year from $76489.0 in Q2 2023, and down 58.65% on a QoQ basis from $2.0 million in Q4 2023.
Glass House Brands (GLAS) Deferred Taxes (2020 - 2024) Analysis & Trends
Glass House Brands (GLAS) has 5 years of Deferred Taxes data on file, last reported at $834000.0 in Q1 2024.
- On a quarterly basis, Deferred Taxes rose 990.35% year-over-year to $834000.0 in Q1 2024; TTM through Mar 2024 was $2.3 million, a 124.08% increase from a year earlier, with the FY2023 full-year figure at $1.5 million, up 113.1% from the prior year.
- Deferred Taxes for Q1 2024 stood at $834000.0, down from $2.0 million in the prior quarter.
- Over the last five years, Deferred Taxes for GLAS reached as high as $2.0 million in Q4 2023 and fell as low as -$9.5 million in Q4 2022.
- Historically, Deferred Taxes has averaged -$561613.9 across 5 years, with a median of -$49920.0 in 2021.
- Across the five-year window, Deferred Taxes slumped 27046.6% in 2022 and jumped 990.35% in 2024, its largest moves.
- Year by year, Deferred Taxes stood at $1.1 million in 2020, then plunged by 103.09% to -$34888.0 in 2021, then slumped by 27046.6% to -$9.5 million in 2022, then soared by 121.3% to $2.0 million in 2023, then slumped by 58.65% to $834000.0 in 2024.
- Per Business Quant data, the three most recent Deferred Taxes figures were $834000.0 in Q1 2024, $2.0 million in Q4 2023, and -$226352.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 25.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 834,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | -226,352.00 |
| Jun 30, 2023 | -355,124.00 |
| Mar 31, 2023 | 76,489.00 |
| Dec 31, 2022 | -9.47 Mn |
| Sep 30, 2022 | 36,300.00 |
| Jun 30, 2022 | -67,132.00 |
| Mar 31, 2022 | -2.04 Mn |
| Dec 31, 2021 | -34,888.00 |
| Sep 30, 2021 | -49,920.00 |
| Jun 30, 2021 | -219,450.00 |
| Mar 31, 2021 | -57,797.00 |
| Dec 31, 2020 | 1.13 Mn |
| Sep 30, 2020 | 2,397.00 |